Atlas Trials

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Clinical trial NCT00103207 · COMPLETED

Trial details

NCT number
NCT00103207
Sponsor
Eastern Cooperative Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2005-10-13
Primary completion
2010-04-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.